RUSLANA JACKSON: Open Payments
NPI 1740515931 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 30 payments from 7 companies in 2025. Trend: 2023 $303 · 2024 $510 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $143 |
| HEARTFLOW, INC. | 6 | $136 |
| Alnylam Pharmaceuticals Inc. | 4 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85 |
| BridgeBio Pharma, Inc. | 3 | $68 |
| Amgen Inc. | 3 | $62 |
| PFIZER INC. | 1 | $38 |
Products named: LEQVIO, FFRct, AMVUTTRA, JARDIANCE, Attruby, ELIQUIS, REPATHA.
Industry payments across NY — which companies pay providers there.
